Articles From: BauerWorld 2014 Expands to Showcase High Performance Sports Platform to Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad Bleeding Disorder Pipeline


2013/10/24
BauerWorld 2014 Expands to Showcase High Performance Sports Platform Canada NewsWire Revolutionary Technologies, Products Unveiled at Industry-Leading Event EXETER, NH , Oct.
Sign-up for BauerWorld 2014 Expands to Showcase High Performance Sports Platform investment picks
Bauer Performance Sports Ltd.
Sign-up for BauerWorld 2014 Expands to Showcase High Performance Sports Platform investment picks
2013/8/14
http://media.marketwire.com/attachments/201009/639319_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1042886&ProfileId=051205&sourceType=1 TUSTIN, CA --
Sign-up for Bavituximab's Mechanism of Action Highlighted at Immunomodulatory Therapeutic Antibodies for Cancer Conference investment picks
2014/3/7
RALEIGH, N.C., March 7, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in the Canaccord Genuity Musculoskeletal Conference on March 11, 2014.
Sign-up for Baxano Surgical Announces Participation in Canaccord Genuity Musculoskeletal Conference investment picks
RALEIGH, N.C., Oct.
Sign-up for Baxano Surgical Announces Patent Issuance for the VEO Lateral Access System investment picks
2014/1/13
RALEIGH, N.C., Jan.
Sign-up for Baxano Surgical Announces Preliminary Fourth Quarter and Full Year 2013 Unaudited Revenue investment picks
2013/12/6
RALEIGH, N.C., Dec.
Sign-up for Baxano Surgical Announces Published Clinical Results on Two Core Technologies investment picks
2014/4/10
RALEIGH, N.C., April 10, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) , a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that it has received U.S. Food and Drug Administration 510(k) clearance (k133743) of its Avance™ MIS Pedicle Screw System, which may be used as an adjunct to fusion in numerous degenerative and complex spinal pathologies.
Sign-up for Baxano Surgical Receives 510(k) Clearance for the Avance MIS Pedicle Screw System investment picks
2014/3/3
RALEIGH, N.C., March 3, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release fourth quarter 2013 financial and operating results after market close on Thursday, March 6, 2014.
Sign-up for Baxano Surgical Schedules Fourth Quarter 2013 Results Conference Call for Thursday, March 6, 2014 investment picks
2014/2/7
RALEIGH, N.C., Feb.
Sign-up for Baxano Surgical Sets Date of 2014 Annual Meeting investment picks
2014/3/11
RALEIGH, N.C., March 11, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) ("Baxano Surgical" or the "Company"), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, announced today that it has entered into a definitive agreement with entities affiliated with two institutional investors in connection with a private placement of approximately $10 million aggregate principal amount of subordinated convertible debentures and warrants to purchase 9,428,000 shares of common stock.
Sign-up for Baxano Surgical, Inc. Announces $10 Million Private Placement of Convertible Debentures investment picks
2014/3/14
RALEIGH, N.C., March 14, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) , a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, today announced changes to its executive management team.
Sign-up for Baxano Surgical, Inc. Announces Changes to Executive Management Team investment picks
2013/9/20
Third Quarter and Full Year Revenue Guidance Reaffirmed RALEIGH, N.C., Sept.
Sign-up for Baxano Surgical, Inc. Announces Changes to Management Team investment picks
- Credit Facility for up to $15.0 Million with Hercules Technology Growth Capital - Stock Purchase Agreement for up to $7.0 Million with Lincoln Park Capital Fund RALEIGH, N.C., Dec.
Sign-up for Baxano Surgical, Inc. Announces Financing Commitments for Up to $22.0 Million investment picks
2013/9/26
AxiaLIF Plus and VEO Regulatory Approval in Mexico and Colombia RALEIGH, N.C., Sept.
Sign-up for Baxano Surgical, Inc. Announces International Expansion investment picks
2013/11/18
RALEIGH, N.C., Nov.
Sign-up for Baxano Surgical, Inc. Announces Participation in Two Healthcare Conferences investment picks
2014/3/6
– Fourth Quarter Revenue Was $6.0 Million – RALEIGH, N.C., March 6, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) , a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, today announced its financial results for the three and twelve months ended December 31, 2013.
Sign-up for Baxano Surgical, Inc. Reports Operating Results for the Fourth Quarter of 2013, Issues First Quarter 2014 Guidance investment picks
- Second Quarter Revenues Were $3.9 Million - RALEIGH, N.C., Aug.
Sign-up for Baxano Surgical, Inc. Reports Operating Results for the Second Quarter of 2013, Issues Third Quarter 2013 Guidance investment picks
2013/11/6
- Third Quarter Revenues Were $5.7 Million – RALEIGH, N.C., Nov.
Sign-up for Baxano Surgical, Inc. Reports Operating Results for the Third Quarter of 2013, Issues Fourth Quarter 2013 Guidance investment picks
RALEIGH, N.C., July 25, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release second quarter 2013 financial and operating results after market close on Thursday, August 8, 2013.
Sign-up for Baxano Surgical, Inc. Schedules Second Quarter 2013 Results Conference Call for Thursday, August 8, 2013 investment picks
By Tess Stynes Baxter International Inc.'s (BAX) third-quarter earnings fell 6.7% on charges related to a recent acquisition, though the drug and medical-device maker's revenue received a boost from the deal.
Sign-up for Baxter 3rd-Quarter Profit Down 6.7 % On Expenses Tied to Gambro Acquisition investment picks
2014/4/10
Baxter International Inc. (NYSE: BAX) announced educational collaborations with local institutions to prepare the current and future workforce for careers, and was recently recognized for safety performance.
Sign-up for Baxter Addresses Community Needs Through Charitable Giving and Educational Partnerships investment picks
2013/11/15
Baxter International Inc. (NYSE:BAX) and Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today jointly announced that they have entered into an exclusive worldwide licensing agreement to develop and commercialize pacritinib.
Sign-up for Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib investment picks
Baxter International Inc. (NYSE:BAX) and Coherus Biosciences, Inc. today announced that they have entered into an exclusive collaboration to develop and commercialize a biosimilar to etanercept for Europe, Canada, Brazil and certain other markets.
Sign-up for Baxter and Coherus Biosciences Announce Collaboration to Develop and Commercialize Biosimilars investment picks
Baxter International Inc. (NYSE:BAX) and JW Holdings today announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products containing a novel formulation of omega 3 lipids.
Sign-up for Baxter and JW Holdings Announce Exclusive Global Development and Commercialization Collaboration for Omega 3 Parenteral Nutrition Products investment picks
2014/3/27
Baxter International Inc. (NYSE: BAX) today announced plans to create two separate, independent global healthcare companies -- one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products.
Sign-up for Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies investment picks
2014/1/30
Baxter International Inc. (NYSE:BAX) has restructured its ongoing agreement with Xenetic Biosciences, Inc. (OTCBB: GAIFD) for the development of BAX 826, a recombinant Factor VIII treatment for hemophilia A under investigation to assess its potential to extend the half-life and duration of effectiveness.
Sign-up for Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad Bleeding Disorder Pipeline investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: BauerWorld 2014 Expands to Showcase High Performance Sports Platform to Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad Bleeding Disorder Pipeline
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity